Image optimize LCP

New Commercialization White Paper 🎉 Click here to read it now!

Menu

New Commercialization White Paper 🎉 Click here to read it now!

Add description, images, menus and links to your mega menu

A column with no settings can be used as a spacer

Link to your collections, sales and even external links

Add up to five columns

  • Add description, images, menus and links to your mega menu

  • A column with no settings can be used as a spacer

  • Link to your collections, sales and even external links

  • Add up to five columns

    • Maternova Research receives funding from Merck for Mothers to conduct clinical trial in Bangladesh

    Main
    Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
    Register: ClinicalTrials.gov
    Last refreshed on: 19 February 2015
    Main ID:  NCT02256995
    Date of registration: 18/09/2014
    Prospective Registration: Yes
    Primary sponsor: Maternova Research
    Public title: uChek Pilot Study for Urinalysis in the Antenatal Care Setting uChekBangla
    Scientific title: A Prospective Observational Pilot Study to Test the Feasibility of Smartphone Enabled uChek Urinalysis Device in Bangladesh
    Date of first enrolment: November 2014
    Target sample size: 375
    Recruitment status: Not yet recruiting
    URL:  http://clinicaltrials.gov/show/NCT02256995
    Study type:  Observational
    Study design:  Observational Model: Cohort, Time Perspective: Prospective  
    Phase:  N/A

     

    Countries of recruitment
    Bangladesh

     

    Contacts
    Name:     Meg E Wirth
    Address: 
    Telephone: 4012286294
    Email: mwirth@maternova.net
    Affiliation: 
    Name:     Janardana Sharma, MD
    Address: 
    Telephone:
    Email:
    Affiliation:  Hope Bangladesh

     

    Key inclusion & exclusion criteria

    Inclusion Criteria:

    - Pregnant with a gestational age of over 22 weeks and ability to follow pregnancy till
    delivery.

    Exclusion Criteria:

    - Study participant is unwilling to take part in study or participants with
    pathological conditions that restrict them from providing a urine sample without
    catheterization.



    Age minimum: N/A
    Age maximum: N/A
    Gender: Female

     

    Health Condition(s) or Problem(s) studied
    Eclampsia
    Preeclampsia
    Pregnancy
    Proteinuria

     

    Intervention(s)
    Device: uChek

     

    Primary Outcome(s)
    Feasibility of using uChek for standard urinalysis in an antenatal care (ANC) setting [Time Frame: 6 months]

     

    Secondary Outcome(s)
    Impressions and attitudes of healthcare workers re: uChek for urinalysis in ANC [Time Frame: 6 months]

     

    Secondary ID(s)
    MATBANG2014

     

    Source(s) of Monetary Support
    Please refer to primary and secondary sponsors

     

    Secondary Sponsor(s)
    HOPE Foundation for Women and Children of Bangladesh
    Merck for Mothers

     

    Ethics review
    Results
    Results available:
    Date Posted:
    Date Completed:
    URL: